Biotalys NV

Biotalys NV is an agricultural technology (AgTech) company dedicated to transforming food protection through the development of protein-based biocontrol solutions. Its mission is to provide sustainable and safe alternatives to conventional chemical pesticides, contributing to a more secure food supply. The company's primary research and corporate functions are headquartered in Ghent, Belgium, with a significant operational and market development presence, including a U.S. headquarters, in Research Triangle Park, North Carolina.

At the core of Biotalys' offerings is its proprietary AGROBODY™ technology platform, also referred to as AGROBODY Foundry™ and AGROBODY 2.0, which enables the rapid generation of novel protein-based crop protection products. The company's lead product, EVOCA™ (formerly known as BioFun-1), is a protein-based biofungicide designed to protect fruits and vegetables against major fungal diseases such as Botrytis cinerea (grey mold) and powdery mildew. These solutions aim to prevent crop loss, extend post-harvest protection, and reduce food waste across the entire food value chain.

In recent developments, Biotalys achieved its first U.S. state registration for EVOCA in Florida in April 2026, following EPA approval in December 2025. The company announced a strategic refocus in February 2026 to prioritize its lead assets and reduce annual cash burn, which included a workforce reduction. Biotalys has also forged key partnerships, including a bioinsecticide development collaboration with Syngenta and agreements with AgroFresh for post-harvest solutions and 21st.BIO to scale up biocontrol production. Kevin Helash serves as the CEO, leading the company's efforts to establish itself as a leader in precision biocontrols.